36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
424B4
e0onkj40qtl3496xo3
11 Oct 22
Prospectus supplement with pricing info
8:27am
DEFM14A
nr3 1xl9zfgkmuzcdn2
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
dmk q8keltlfh0v5l
11 Dec 18
Preliminary proxy related to merger
5:23pm